Cite
HARVARD Citation
Bahashwan, S. et al. (n.d.). Outcome and impact of post‐remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia. American journal of hematology. 94 (1), pp. E32-E35. [Online].